The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has recommended granting emergency use authorization (EUA) to Bharat Biotech’s Covaxin for vaccination of 2 to 18-year-olds against covid-19. Mint explains:

from mint - Science https://ift.tt/3AxVIFm
https://ift.tt/eA8V8J

Post a Comment

Previous Post Next Post